Optic Nerve Atrophy Treatment Market: How Is Gene Therapy...

agregó una foto Health

2026-07-01 07:24:57 -

Optic Nerve Atrophy Treatment Market: How Is Gene Therapy Transforming the Landscape for Hereditary Optic Neuropathies?

Gene therapy-driven optic nerve atrophy treatment — the antisense oligonucleotide, AAV-mediated gene replacement, and CRISPR-based approaches for autosomal dominant optic atrophy (ADOA) and Leber hereditary optic neuropathy (LHON) representing the fastest-growing therapeutic innovation in the global optic atrophy market — creates the most commercially promising pipeline segment,...

0 Commentarios 0 Acciones 9 Views 0 Vista previa